Summit Trail Advisors LLC Grows Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Summit Trail Advisors LLC raised its position in HCA Healthcare, Inc. (NYSE:HCA) by 13.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,612 shares of the company’s stock after acquiring an additional 433 shares during the quarter. Summit Trail Advisors LLC’s holdings in HCA Healthcare were worth $1,468,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. Alpha DNA Investment Management LLC purchased a new position in HCA Healthcare in the 3rd quarter valued at approximately $869,000. Larson Financial Group LLC boosted its holdings in HCA Healthcare by 201.3% in the third quarter. Larson Financial Group LLC now owns 672 shares of the company’s stock valued at $273,000 after purchasing an additional 449 shares during the period. Swedbank AB increased its holdings in HCA Healthcare by 1.2% during the 3rd quarter. Swedbank AB now owns 286,219 shares of the company’s stock worth $116,328,000 after purchasing an additional 3,436 shares during the period. Canopy Partners LLC acquired a new position in shares of HCA Healthcare during the third quarter worth about $208,000. Finally, Kingsview Wealth Management LLC raised its holdings in HCA Healthcare by 396.1% in the third quarter. Kingsview Wealth Management LLC now owns 7,387 shares of the company’s stock valued at $3,002,000 after acquiring an additional 5,898 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Down 2.2 %

Shares of HCA Healthcare stock opened at $324.93 on Monday. HCA Healthcare, Inc. has a one year low of $245.84 and a one year high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm has a fifty day moving average of $379.40 and a two-hundred day moving average of $358.70. The company has a market cap of $82.30 billion, a P/E ratio of 14.59, a PEG ratio of 1.25 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is 11.85%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Royal Bank of Canada raised their price objective on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price objective for the company. Finally, UBS Group lifted their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Six equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $385.00.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,155 shares of company stock worth $5,608,990 over the last three months. 1.70% of the stock is currently owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.